Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-market Registry Study on the Safety and Efficacy of ZENFLEX Pro™ Peripheral Drug-eluting Stent System for Femoropopliteal Artery Lesions

NCT07049120 is registered in ClinicalTrials.gov with Zhejiang Zylox Medical Device Co., Ltd. as lead sponsor.

NCT NCT07049120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07049120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-market Registry Study on the Safety and Efficacy of ZENFLEX Pro™ Peripheral Drug-eluting Stent System for Femoropopliteal Artery Lesions
Lead sponsor
Zhejiang Zylox Medical Device Co., Ltd.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 30, 2025
Completion date
October 31, 2027
Enrollment
153 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral arterial disease